Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gottlieb Leaves FDA Feeling Good About Generic Approvals, But Concerned About Innovative Competition

FDA Commissioner Scott Gottlieb in his office — • Source: FDA photo by Michael J. Ermarth

Related Content

Opioid Use Disorder: Is Reduced Usage A Better Endpoint Than Abstinence?

Apr 24 2018

Kratom Advocates Urge Industry Compliance, FDA And DEA Compassion

Mar 08 2018

FDA Ends ANDA 'Reviews' To Streamline Approval Process

Jan 04 2018

Opioid REMS Revisions Reflect Some, Not All, Stakeholder Concerns

Feb 01 2018

Complete Response Letters: US FDA Trying To Identify Subsets For Public Release

Jan 17 2018

US FDA's Gottlieb Touts 'Seamless' Clinical Trials, Worries About Second-To-Market Products

Jul 26 2018

Sales of Drug-Spiked Nicotine Could Sink E-Cigarettes' Smoking Cessation Chances

Oct 11 2018

US FDA Sets Generic Approval Record, But Generic Sponsors Aren't Celebrating

Oct 12 2018

REMS Abuse Website: All Sizzle, No Steak?

Sep 06 2018

US FDA Wants Opioid Prescribing Guidelines To Be Highly Specific, But It May Have To Compromise

Feb 08 2019

New Acting US FDA Commissioner Shares Agency's Clinical Trial Reform Message

Mar 13 2019

Gottlieb Touts US FDA's Organizational Structure For Advancing Policies During His Tenure

Mar 20 2019

Opioid Blister-Pack Mandate Tops Gottlieb's Agenda With New Authority

Oct 22 2018

Opioid REMS Increases Nearly Six-Fold As US FDA Adds Immediate-Release Products

Sep 19 2018

Opioid Approvals: Congress Wants US FDA Guidance On Abuse Potential

Oct 01 2018

REMS Abuse Website: Has It Changed The Behavior Of Innovators?

Feb 12 2019

Curtain Falls On Opana ER As Endo Agrees To US FDA Withdrawal Request

Jul 06 2017

Drug Pricing: Could Expedited Review Of Competing Brands Create The Desired Pressure?

Jul 20 2017

Waivers For Shared REMS Will Depend On Impact To Generics, Docs, Patients

Jun 01 2018

REMS Abuse Website: Celgene, Actelion Top List Of Suspected 'Gamers'

May 18 2018

Initiator Or Facilitator? Gottlieb Reflects On First Year As Head Of US FDA

May 12 2018

Gottlieb Takes Aim At CROs’ ‘Outdated Processes’ In Push For Clinical Trial Digitization

Nov 26 2018

With High Profile At FDA, Gottlieb Headed Ambitious Consumer Health Initiatives

Mar 06 2019

INFOGRAPHIC: Hepatitis C Market Still Has Room To Grow

Aug 01 2016

Related Companies

Gilead Sciences, Inc.

AbbVie Inc.

Endo, Inc.

Additional Topics

United States Leadership FDA Regulation BioPharmaceutical

More from Agency Leadership

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window